588 related articles for article (PubMed ID: 20227347)
1. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
2. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Sever PS; Poulter NR
Lancet; 2010 Mar; 375(9718):895-905. PubMed ID: 20226988
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
6. Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
Gupta A; Whiteley WN; Godec T; Rostamian S; Ariti C; Mackay J; Whitehouse A; Janani L; Poulter NR; Sever PS;
Eur Heart J; 2024 Apr; 45(13):1159-1169. PubMed ID: 38291599
[TBL] [Abstract][Full Text] [Related]
7. Reduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/perindopril combination to reduce stroke risk.
Aalbers J
Cardiovasc J Afr; 2010; 21(2):115. PubMed ID: 20532438
[TBL] [Abstract][Full Text] [Related]
8. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Poulter NR; Dobson JE; Sever PS; Dahlöf B; Wedel H; Campbell NR;
J Am Coll Cardiol; 2009 Sep; 54(13):1154-61. PubMed ID: 19761936
[TBL] [Abstract][Full Text] [Related]
9. The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
Pharmacoeconomics; 2009; 27(3):221-30. PubMed ID: 19354342
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
11. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
[TBL] [Abstract][Full Text] [Related]
12. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
van den Meiracker AH; van Montfrans GA
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):886-8. PubMed ID: 16686086
[TBL] [Abstract][Full Text] [Related]
13. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Gupta AK; Dahlof B; Dobson J; Sever PS; Wedel H; Poulter NR;
Diabetes Care; 2008 May; 31(5):982-8. PubMed ID: 18235048
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
Payeras AC; Sladek K; Lembo G; Alberici M
Clin Drug Investig; 2007; 27(9):623-32. PubMed ID: 17705571
[TBL] [Abstract][Full Text] [Related]
15. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
16. Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Collier DJ; Poulter NR; Dahlöf B; Sever PS; Wedel H; Buch J; Caulfield MJ;
J Hypertens; 2011 Mar; 29(3):583-91. PubMed ID: 21297503
[TBL] [Abstract][Full Text] [Related]
17. Effects of different antihypertensive drugs on blood pressure variability in patients with ischemic stroke.
Ji M; Li SJ; Hu WL
Eur Rev Med Pharmacol Sci; 2014; 18(17):2491-5. PubMed ID: 25268094
[TBL] [Abstract][Full Text] [Related]
18. Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke.
Webb AJ; Wilson M; Lovett N; Paul N; Fischer U; Rothwell PM
Stroke; 2014 Oct; 45(10):2967-73. PubMed ID: 25147330
[TBL] [Abstract][Full Text] [Related]
19. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
Mancia G; Facchetti R; Parati G; Zanchetti A
Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV).
Lee JW; Choi E; Son JW; Youn YJ; Ahn SG; Ahn MS; Kim JY; Lee SH; Yoon J; Ryu DR; Park SM; Hong KS; Yoo BS
Am J Hypertens; 2020 Aug; 33(8):748-755. PubMed ID: 32267481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
